AI-Powered Clinical Trials Market By Application: Patient Recruitment, Data Analysis, By End-Use: Pharmaceutical Companies, Research Institutions, By End-Use: Pharmaceutical Companies, Research Institutions, Segment Forecasts: 2024 - 2030
AI-Powered Clinical Trials Market Trends
The AI-powered clinical trials market was valued at USD 1.8 billion in 2024 and is expected to grow at a CAGR of 35.4% from 2025 to 2030. The integration of AI technologies is revolutionizing the clinical trial process by enhancing patient recruitment and data analysis.
Product Insights
Patient recruitment applications accounted for the largest market share in 2024, contributing 57.8% of total revenue. Data analysis applications are also expanding significantly, as AI tools improve the efficiency and accuracy of trial data management.
End-Use Insights
Pharmaceutical companies represented the largest end-users in 2024, holding a 66.2% market share, as they adopt AI solutions to optimize clinical trial processes. Research institutions are also increasingly leveraging AI technologies for more efficient trial management.
Regional Insights
North America dominated the AI-powered clinical trials market with a 54.8% share in 2024, driven by high investments in AI technologies and a strong pharmaceutical sector. The Asia Pacific region is projected to experience substantial growth, with a CAGR of 38.6%, as awareness of AI benefits increases.
GET A FREE SAMPLE
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.